Contact Us


News





Plenary Speakers Announced

Dr. Samuel Stupp

Dr. George V. Ludwig

Dr. Kiran Masunuru




Important Dates:



Promotional Material:

Call for Abstracts Announcements: 4:3 | Widescreen

 






2017 Sponsors:

Gold

Burroughs Wellcome Fund


Silver

Wake Forest Institute for Regenerative Medicine (WFIRM)


Bronze

CELLINK

McGowan Institute of Regenerative Medicine at the University of Pittsburgh (MIRM)

PeproTech, Inc.

Tissue Source, LLC


Business Plan Competition Sponsor

BioLife Solutions


Pre-Conference Workshop Sponsor - Imaging and Assessment of Engineered Tissues

Perimed







2017 Exhibitors:

Advanced BioMatrix

Aspect Biosystems

BioSpherix Medical

Burroughs Wellcome Fund

CELLINK

CellScale Biomaterials Testing

Evonik Corporation

Flexcell International Corporation

HypOxygen

International Institute for the Advancement of Medicine (IIAM)

IOP Publishing

JPK Instruments USA, Inc.

Lifecore Biomedical

Mary Ann Liebert, Inc.

McGowan Institute of Regenerative Medicine at the University of Pittsburgh (MIRM)

Nanoscribe GmbH

Nitta Gelatin

PeproTech, Inc.

Perimed Inc.

Rheolution Inc.

SERVA Electrophoresis GmbH

STEMCELL Technologies, Inc.

Tissue By Net

Tissue Source, LLC

University of Alberta / Banff Foundation for Allograft Pathology

Wake Forest Institute for Regenerative Medicine (WFIRM)

 







Organized By:

TERMIS-AM Meeting is organized by the
Tissue Engineering & Regenerative Medicine International Society.

Pre-Conference Workshops

All workshops are being held Sunday, December 3, 2017.

 

Tools for Imaging and Assessment of Engineered Tissues
9:30 AM – 2:30 PM

There is a significant need for the development and application of novel imaging and assessment technologies for analysis of engineered tissues and biomaterials. Researchers often rely on microscopy of histological and immunohistochemical stained samples.  However, a broad range of tools are currently available and new methodologies are continually under development that provide TERMIS with new insights into the performance of their tissue engineering             strategies. The goal of the workshop is to provide TERMIS engineers and      scientist with information about tools available for analysis and imaging of engineered tissues. The first half of the workshop will involve presentations from industry representatives describing the capabilities of their technologies and the potential for use in TERM. The afternoon session will involve speakers developing and applying new tools that could enhance TERM research programs. The workshop will inform researchers of new tools but also engage researchers from outside the field to new applications for their techniques.



Women in Science - Translational Development of TERM Women in Tissue Engineering and Regenerative Medicine Luncheon
11:00 AM – 2:30 PM
 
Invited discussants and speakers: The panel will consist of members from TERM industries, TERM entrepreneurs, academic institutions with partnership with TERM industries and start-ups. 

TERMIS-AM 2017 will be hosted in North Carolina, one of the hubs for TERM industry.  In the last 3 decades, TERM research areas have undergone much advancement and groundbreaking research development.  TERM products have been marketed and a lot more are now reaching the clinical trial stage. Meanwhile, research funding agencies around the globe are promoting academic-industry partnership by providing industry collaborative funding, which further fosters partnership between academic institutions and TERM industries.

Women in TERM luncheon at TERMIS-AM 2017 is organized for women who are keen to learn about the opportunities and development of TERM industry as well as research partnership with TERM industry.  We aim to discuss:

Each panelist will be given 10 minutes to share their experiences and the remaining time will be allocated for active discussions and questions from the audience.  Audience members will also be given the opportunity to network with the speakers and their peers at the luncheon.


Funding, Communication and Negotiation in Academia and Industry
1:00 PM – 3:30 PM

Session Description coming soon!



Cell and Tissue Manufacturing Innovation
1:00 PM – 3:30 PM
This pre-conference workshop entitled, “Cell and Tissue              Manufacturing Innovation” will provide a comprehensive overview of the current stage of manufacturing in tissue engineering and regenerative medicine. Diverse stakeholders and perspectives will be           presented that cover academic translational programs, development of standards for regenerative medicine manufacturing, industry perspectives, and government initiatives. The US Federal Government has been supporting Tissue Engineering and Regenerative Medicine for almost three decades, currently at a robust level of $1B per year where the Multi-Agency Tissue Engineering Sciences (MATES) working group provides a long-standing coordination mechanism for these efforts. The session will conclude with a round table discussion from these diverse stakeholders to          summarize the key developments and challenges in this important area of cell and tissue manufacturing.

 

Speaker and talks:
1:00PM – 1:05PM

Welcome
Joshua Hunsberger, Martha Lundberg, Richard McFarland – Co-chairs
1:05PM – 1:20PM

Academic Translational Programs: Gearing up for Manufacturing
Julie Allickson, Director, Translational Research, Wake Forest School of Medicine
1:20PM – 1:35PM                

Developing Standards for Regenerative Medicine Manufacturing
Carl Simon, Project Leader, National Institute of Standards and Technology
1:35PM – 1:50PM                

Industry Perspectives on Manufacturing Challenges
Jon Rowley, Founder and Chief Technical Officer, RoosterBio, Inc.
1:50PM – 2:05PM                

Body-on-a-chip and Personalized Medicine
Tom Shupe, Assistant Professor, Wake Forest Institute for Regenerative Medicine
2:05PM – 2:15PM                

Break
2:15PM – 2:30PM                

Government Manufacturing Programs
Lester Martinez-Lopez, Major General (RET), U.S. Army, and Chairman, Medical Technology Enterprise Consortium
2:30PM – 2:45PM                

21st Cures Act Bill and Implementation
Amy Patterson, Director, NHLBI Scientific Research Program, Policy, and Strategic Initiatives, National Institutes of Health
2:45PM – 3:00PM                

National Academy Regenerative Medicine Forum
Sarah Beachy, Senior Program Officer and Project Director, National Academy of Sciences, Engineering, and Medicine